Hims & Hers stock closes at one-year low amid battle over compounded Wegovy pill

Hims & Hers also said it’s selling a cancer-detection test that’s featured in its Super Bowl ad, which plays like a ...

A Cheaper Wegovy Pill Alternative Is Hitting the Market. Here’s What You Need to Know

By comparison, Novo Nordisk’s Wegovy pill—launched earlier this year and already used by more than 170,000 people, CEO Mike ...
BioPharma Dive

Hims cancels plans to sell compounded GLP-1 pill after FDA backlash

Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment.
Live Science on MSN

Wegovy now comes in pill form — here's how it works

The pill version of Wegovy seems to work just as well as the injectable form, but there are some key differences between the two formulations, experts say.
Fierce Pharma

Novo adds star-studded first Super Bowl spot to Wegovy pill’s ‘dramatic’ rollout blitz

Amid the fast-moving rollout of the Wegovy pill, Novo Nordisk has taken to advertising’s biggest stage to help get the word ...

Experimental cholesterol-lowering pill may offer new option for millions

It’s still experimental but the pill helps rid the body of cholesterol in a way that today can be done only with injected ...

Analysis-Hims' $49 weight-loss pill rattles investor case for cash-pay obesity market

By Maggie Fick and Bhanvi Satija LONDON, Feb 6 (Reuters) - Hims & Hers' gambit to sell a $49 compounded version of Novo ...

Facing Regulatory Scrutiny, Hims & Hers Withdraws Knockoff Obesity Pill

Federal officials had warned that the new product from the online provider of weight loss drugs might be illegal.